Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.

Sakurai M, Kikuchi T, Karigane D, Kasahara H, Matsuki E, Hashida R, Yamane Y, Abe R, Koda Y, Toyama T, Kato J, Shimizu T, Yokoyama Y, Suzuki S, Nakamura T, Okamoto S, Mori T.

Int J Hematol. 2019 Mar;109(3):292-298. doi: 10.1007/s12185-019-02596-z. Epub 2019 Jan 24.

PMID:
30680668
2.

[Differential Diagnosis of Erythrocytosis - Background and Clinical Relevance].

Wille K, Sadjadian P, Griesshammer M.

Dtsch Med Wochenschr. 2019 Jan;144(2):128-135. doi: 10.1055/a-0739-8340. Epub 2019 Jan 23. Review. German.

PMID:
30674061
3.
4.

Angelica sinensis polysaccharide induces erythroid differentiation of human chronic myelogenous leukemia k562 cells.

Wang L, Jiang R, Song SD, Hua ZS, Wang JW, Wang YP.

Asian Pac J Cancer Prev. 2015;16(9):3715-21.

5.

How I treat polycythemia vera.

Vannucchi AM.

Blood. 2014 Nov 20;124(22):3212-20. doi: 10.1182/blood-2014-07-551929. Epub 2014 Oct 2.

PMID:
25278584
6.

Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells.

McCranor BJ, Kim MJ, Cruz NM, Xue QL, Berger AE, Walston JD, Civin CI, Roy CN.

Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):126-33. doi: 10.1016/j.bcmd.2013.09.004. Epub 2013 Oct 9. Erratum in: Blood Cells Mol Dis. 2014 Apr;52(4):236.

7.

Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line.

Ferguson J, Bird C, Wadhwa M, Burns C.

J Immunol Methods. 2013 Jan 31;387(1-2):191-8. doi: 10.1016/j.jim.2012.10.014. Epub 2012 Nov 8.

PMID:
23142458
8.

Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C.

Kobayashi T, Hige S, Terashita K, Nakai M, Horimoto H, Sho T, Nakanishi M, Ogawa K, Chuma M, Sakamoto N, Asaka M.

J Gastroenterol. 2012 Nov;47(11):1228-37. doi: 10.1007/s00535-012-0579-y. Epub 2012 Mar 30.

PMID:
22460221
10.

Effect of splenectomy on pancytopenia after a peripheral blood stem cell transplantation.

Ding J, Bao W, Wang J, Zhao G, Chen J, Song H.

Cell Transplant. 2011;20(7):1109-15. doi: 10.3727/096368910X544951. Epub 2010 Nov 19.

PMID:
21092413
11.

Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome.

Ma W, Kantarjian H, Zhang K, Zhang X, Wang X, Chen C, Donahue AC, Zhang Z, Yeh CH, O'Brien S, Garcia-Manero G, Caporaso N, Landgren O, Albitar M.

BMC Med Genet. 2010 Nov 16;11:163. doi: 10.1186/1471-2350-11-163.

12.

The anemia of heart failure.

Silverberg DS, Wexler D, Palazzuoli A, Iaina A, Schwartz D.

Acta Haematol. 2009;122(2-3):109-19. doi: 10.1159/000243795. Epub 2009 Nov 10.

PMID:
19907148
13.

Thrombocytosis in EPO-treated dialysis patients may be mediated by EPO rather than iron deficiency.

Vaziri ND.

Am J Kidney Dis. 2009 May;53(5):733-6. doi: 10.1053/j.ajkd.2008.12.030. Epub 2009 Mar 21. No abstract available.

PMID:
19303685
14.

Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response.

Sanchez-Guijo FM, Hernandez JM, Lumbreras E, Morais P, Santamaría C, Garcia JL, Gutierrez NC, Miguel JF, Del Cañizo MC.

Leuk Res. 2009 Jan;33(1):170-3. doi: 10.1016/j.leukres.2008.07.014. Epub 2008 Aug 21.

PMID:
18722011
15.

Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.

Tutaeva V, Misurin AV, Michiels JJ, Rozenberg JM, Sokolova MA, Ivanova VL, Kolosheinova TI, Manakova TE, Levina AA, Semenova EA, Khoroshko ND.

Hematology. 2007 Dec;12(6):473-9.

PMID:
17852451
16.

Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies.

Veselovska J, Pospisilova D, Pekova S, Horvathova M, Solna R, Cmejlova J, Cmejla R, Belickova M, Mihal V, Stary J, Divoky V.

Leuk Res. 2008 Mar;32(3):369-77. Epub 2007 Aug 23.

PMID:
17719087
17.

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.

Leuk Res. 2007 Aug;31(8):1031-8. Epub 2007 Mar 23. Review.

PMID:
17367853
18.
19.

Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.

Zaleskas VM, Krause DS, Lazarides K, Patel N, Hu Y, Li S, Van Etten RA.

PLoS One. 2006 Dec 20;1:e18.

20.

Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.

Tsiara SN, Chaidos A, Bourantas LK, Kapsali HD, Bourantas KL.

Acta Haematol. 2007;117(3):156-61. Epub 2006 Dec 6.

PMID:
17159338

Supplemental Content

Loading ...
Support Center